Sierra Oncology Inc (SRRA) KOL Panel Highlights Momelotinib’s Efficacy - H.C. Wainwright
Go back to Sierra Oncology Inc (SRRA) KOL Panel Highlights Momelotinib’s Efficacy - H.C. Wainwright(NASDAQ: SRRA) | Delayed: 54.99 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $54.99 | 52 Week High | $ | |||
Open | $54.99 | 52 Week Low | $ | |||
Day High | $54.99 | P/E | N/A | |||
Day Low | $54.99 | EPS | $ | |||
Volume | 195,753 |